MBRX logo

Moleculin Biotech (MBRX) EBITDA

Annual EBITDA

-$29.50 M
+$1.01 M+3.30%

December 31, 2023

Summary

Performance

1-Year Change

+3.3%

3-Year Change

-50.98%

5-Year Change

-97.26%

15-Year Change

-241.68%

MBRX EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

43.68%
MBRX annual EBITDA is higher than 43.68% of companies in Healthcare sector

High & Low

All-time High

-$3.88 M

3-Year Low

-$30.51 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
MBRX previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Mar 21, 2025
MBRX next annual earnings announcement is scheduled for Mar 21, 2025

OtherMBRXprofitabilitymetrics:

Annual Revenue

-
MBRX annual revenue value is unknown

Annual Net Income

-$29.77 M
MBRX annual net profit is -$29.77 million

Annual EBIT

-$29.63 M
MBRX annual earnings before interest & taxes is -$29.63 million

Annual EPS

-$15.15
MBRX annual earnings per share is -$15.15

Quarterly EBITDA

-$7.10 M
-$949.00 K-15.42%

September 30, 2024

Summary

Performance

3-Month Change

-15.42%

1-Year Change

-6.89%

3-Year Change

-11.33%

5-Year Change

-11.33%

MBRX Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

41.78%
MBRX quarterly EBITDA is higher than 41.78% of companies in Healthcare sector

High & Low

All-time High

-$321.00 K

3-Year Low

-$9.05 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
MBRX previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 21, 2025
MBRX next earnings announcement is scheduled for Mar 21, 2025

OtherMBRXprofitabilitymetrics:

Quarterly Revenue

-
MBRX quarterly revenue value is unknown

Quarterly Net Income

-$10.59 M
MBRX quarterly net profit is -$10.59 million

Quarterly EBIT

-$7.13 M
MBRX quarterly earnings before interest & taxes is -$7.13 million

Quarterly EPS

-$2.85
MBRX quarterly earnings per share is -$2.85

TTM EBITDA

-$28.79 M
-$1.19 M-4.30%

September 30, 2024

Summary

Performance

3-Month Change

-4.3%

1-Year Change

-3.46%

3-Year Change

+6.45%

5-Year Change

+6.45%

MBRX TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

42.63%
MBRX TTM EBITDA is higher than 42.63% of companies in Healthcare sector

High & Low

All-time High

-$321.00 K

3-Year Low

-$31.79 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
MBRX previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 21, 2025
MBRX next earnings announcement is scheduled for Mar 21, 2025

OtherMBRXprofitabilitymetrics:

TTM Revenue

-
MBRX TTM revenue value is unknown

TTM Net Income

-$30.15 M
MBRX TTM net profit is -$30.15 million

TTM EBIT

-$28.92 M
MBRX TTM earnings before interest & taxes is -$28.92 million

TTM EPS

-$11.78
MBRX TTM earnings per share is -$11.78

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

-$29.50 M
MBRX annual EBITDA is -$29.50 million

Annual Net Income

-$29.77 M
MBRX annual net profit is -$29.77 million

Annual Interest Expense

-
MBRX annual interest expense value is unknown

Annual Income Tax

-
MBRX annual income tax value is unknown

Annual D&A

$127.00 K
MBRX annual depreciation & amortization is $127.00 thousand

MBRX EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+3.3%-6.9%-3.5%
3 y3 years-51.0%-11.3%+6.5%
5 y5 years-97.3%-11.3%+6.5%

MBRX EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-29.4%+3.3%-37.4%+21.5%-26.2%+9.5%
5 y5-year-70.3%+3.3%-105.9%+21.5%-66.2%+9.5%
alltimeall time-661.0%+3.3%-2112.8%+21.5%-8867.6%+9.5%

Moleculin Biotech EBITDA History

DateAnnualQuarterlyTTM
Sep 2024
-
-$7.10 M(+15.4%)
-$28.79 M(+4.3%)
Jun 2024
-
-$6.15 M(-7.4%)
-$27.60 M(-0.8%)
Mar 2024
-
-$6.64 M(-25.2%)
-$27.82 M(-5.7%)
Dec 2023
-$29.50 M(-3.3%)
-$8.88 M(+50.2%)
-$29.50 M(+6.8%)
Sep 2023
-
-$5.92 M(-7.3%)
-$27.64 M(-10.2%)
Jun 2023
-
-$6.38 M(-23.4%)
-$30.77 M(-3.2%)
Mar 2023
-
-$8.32 M(+18.6%)
-$31.79 M(+4.2%)
Dec 2022
-$30.51 M(+33.8%)
-$7.02 M(-22.5%)
-$30.51 M(+6.4%)
Sep 2022
-
-$9.05 M(+22.3%)
-$28.66 M(+11.4%)
Jun 2022
-
-$7.40 M(+5.1%)
-$25.73 M(+8.1%)
Mar 2022
-
-$7.04 M(+36.2%)
-$23.80 M(+4.4%)
Dec 2021
-$22.80 M(+16.7%)
-$5.17 M(-15.4%)
-$22.80 M(+8.2%)
Sep 2021
-
-$6.12 M(+11.7%)
-$21.08 M(+0.1%)
Jun 2021
-
-$5.47 M(-9.4%)
-$21.06 M(+2.4%)
Mar 2021
-
-$6.04 M(+75.2%)
-$20.57 M(+5.3%)
Dec 2020
-$19.54 M
-$3.45 M(-43.4%)
-$19.54 M(-6.3%)
Sep 2020
-
-$6.09 M(+22.3%)
-$20.85 M(+8.5%)
DateAnnualQuarterlyTTM
Jun 2020
-
-$4.98 M(-0.7%)
-$19.22 M(+7.9%)
Mar 2020
-
-$5.02 M(+5.4%)
-$17.82 M(+2.8%)
Dec 2019
-$17.32 M(+15.8%)
-$4.76 M(+6.8%)
-$17.32 M(+2.8%)
Sep 2019
-
-$4.46 M(+24.4%)
-$16.86 M(+12.5%)
Jun 2019
-
-$3.58 M(-20.8%)
-$14.98 M(-11.1%)
Mar 2019
-
-$4.52 M(+5.3%)
-$16.85 M(+12.7%)
Dec 2018
-$14.96 M(+73.2%)
-$4.30 M(+66.6%)
-$14.96 M(+6.5%)
Sep 2018
-
-$2.58 M(-52.7%)
-$14.05 M(+1.3%)
Jun 2018
-
-$5.45 M(+107.3%)
-$13.87 M(+42.5%)
Mar 2018
-
-$2.63 M(-22.4%)
-$9.73 M(+31.0%)
Dec 2017
-$8.63 M(+122.7%)
-$3.39 M(+41.2%)
-$7.43 M(+36.2%)
Sep 2017
-
-$2.40 M(+82.4%)
-$5.45 M(+21.9%)
Jun 2017
-
-$1.31 M(+305.9%)
-$4.47 M(+15.3%)
Mar 2017
-
-$324.00 K(-77.1%)
-$3.88 M(+0.1%)
Dec 2016
-$3.88 M
-$1.41 M(-0.6%)
-$3.88 M(+57.3%)
Sep 2016
-
-$1.42 M(+96.5%)
-$2.46 M(+136.1%)
Jun 2016
-
-$723.00 K(+125.2%)
-$1.04 M(+225.2%)
Mar 2016
-
-$321.00 K
-$321.00 K

FAQ

  • What is Moleculin Biotech annual EBITDA?
  • What is the all time high annual EBITDA for Moleculin Biotech?
  • What is Moleculin Biotech annual EBITDA year-on-year change?
  • What is Moleculin Biotech quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Moleculin Biotech?
  • What is Moleculin Biotech quarterly EBITDA year-on-year change?
  • What is Moleculin Biotech TTM EBITDA?
  • What is the all time high TTM EBITDA for Moleculin Biotech?
  • What is Moleculin Biotech TTM EBITDA year-on-year change?

What is Moleculin Biotech annual EBITDA?

The current annual EBITDA of MBRX is -$29.50 M

What is the all time high annual EBITDA for Moleculin Biotech?

Moleculin Biotech all-time high annual EBITDA is -$3.88 M

What is Moleculin Biotech annual EBITDA year-on-year change?

Over the past year, MBRX annual EBITDA has changed by +$1.01 M (+3.30%)

What is Moleculin Biotech quarterly EBITDA?

The current quarterly EBITDA of MBRX is -$7.10 M

What is the all time high quarterly EBITDA for Moleculin Biotech?

Moleculin Biotech all-time high quarterly EBITDA is -$321.00 K

What is Moleculin Biotech quarterly EBITDA year-on-year change?

Over the past year, MBRX quarterly EBITDA has changed by -$458.00 K (-6.89%)

What is Moleculin Biotech TTM EBITDA?

The current TTM EBITDA of MBRX is -$28.79 M

What is the all time high TTM EBITDA for Moleculin Biotech?

Moleculin Biotech all-time high TTM EBITDA is -$321.00 K

What is Moleculin Biotech TTM EBITDA year-on-year change?

Over the past year, MBRX TTM EBITDA has changed by -$962.00 K (-3.46%)